Identified as
  • v4.0.2
  • FAQ
  • SIGN UP / LOGIN
  • LOGIN
Investor List:

Top Diagnostics Series A Investors in Washington, D.C. (7)

INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
Photo of George C. Petrocheilos, Managing Partner at Catalio Capital
George C. Petrocheilos
Catalio CapitalManaging Partner
n/a
$1.5M
($100K - $5.0M)
Investors in Baltimore (MD), Investors in Athens (Greece), Investors in New York (NY)
Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Seed), Investors in Robotics (Series B), Investors in Robotics (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in New York City (Other Lists), Investors in Medical Devices (Seed), Investors in Medical Devices (Seed), Investors in Robotics (Seed), Investors in Robotics (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in Robotics (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in Robotics (Series A), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Medical Devices (Series B), Investors in Robotics (Series B), Investors in Washington, D.C. (Other Lists), Investors in Cybersecurity (Seed), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series B), Investors in Cybersecurity (Series A), Investors in Diagnostics (Series B), Investors in Cybersecurity (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Cybersecurity (Series A), Investors in Cybersecurity (Seed), Investors in Cybersecurity (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed)
+52
Photo of R. Jacob Vogelstein, Managing Partner at Catalio Capital
R. Jacob Vogelstein
Catalio CapitalManaging Partner
n/a
$1.5M
($100K - $5.0M)
Investors in Washington (D.C.), Investors in Baltimore (MD), Investors in Bethesda
Investors in AI (Series B), Investors in BioTech (Series B), Investors in Medical Devices (Series B), Investors in Medical Devices (Series A), Investors in BioTech (Series A), Investors in AI (Series A), Investors in AI (Series A), Investors in BioTech (Series A), Investors in Medical Devices (Series A), Investors in BioTech (Series B), Investors in AI (Series B), Investors in Medical Devices (Series B), Investors in Washington, D.C. (Other Lists), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B)
+17
Photo of Elias Zerhouni, Venture Partner at Catalio Capital
Elias Zerhouni
Catalio CapitalVenture Partner
n/a
$1.5M
($100K - $5.0M)
Investors in Baltimore (MD)
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Washington, D.C. (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed), Investors in Pharmaceuticals (Pre-seed), Investors in Diagnostics (Pre-seed)
+10
Photo of Bert Vogelstein, Venture Partner at Catalio Capital
Bert Vogelstein
Catalio CapitalVenture Partner
n/a
$1.5M
($100K - $5.0M)
Investors in Cambridge (MA), Investors in Boston (MA), Investors in Baltimore (MD)
Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Washington, D.C. (Other Lists), Investors in Boston / New England (Other Lists), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed)
+9
Photo of Alison (Ali) Perez, Investor at Lockheed Martin Ventures
Alison (Ali) Perez
Lockheed Martin VenturesInvestor
n/a
$2.5M
($500K - $5.0M)
Investors in Washington (DC)
Investors in AI (Series B), Investors in Data Services (Series B), Investors in Data Services (Seed), Investors in IoT (Seed), Investors in IoT (Series B), Investors in Data Services (Series A), Investors in IoT (Series A), Investors in AI (Seed), Investors in AI (Seed), Investors in Health IT (Series A), Investors in Data Services (Seed), Investors in AI (Series A), Investors in Health IT (Seed), Investors in IoT (Seed), Investors in AI (Series A), Investors in Data Services (Series A), Investors in Health IT (Series A), Investors in IoT (Series A), Investors in AI (Series B), Investors in Data Services (Series B), Investors in Health IT (Series B), Investors in IoT (Series B), Investors in Washington, D.C. (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in Digital Health (Series A), Investors in Digital Health (Series B), Investors in Health IT (Seed), Investors in Health IT (Series B), Investors in Digital Health (Series A), Investors in Digital Health (Seed)
+32
Photo of Andrew Lee, Senior Associate at Northpond Ventures
Andrew Lee
Northpond VenturesSenior Associate
n/a
$10
($1 - $40)
Investors in Washington (D.C.), Investors in San Francisco (CA)
Investors in AgTech (Series B), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in AgTech (Seed), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Series B), Investors in Chemicals (Seed), Investors in Chemicals (Series B), Investors in BioTech (Seed), Investors in Diverse Investors (Other Lists), Investors in AgTech (Seed), Investors in Investors who invested in female founders (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Investors who invested in diverse founders (Other Lists), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Chemicals (Seed), Investors in AgTech (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in Chemicals (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Chemicals (Series A), Investors in Pharmaceuticals (Series A), Investors in AgTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Chemicals (Series A), Investors in AgTech (Series B), Investors in BioTech (Series B), Investors in Chemicals (Series B), Investors in Washington, D.C. (Other Lists), Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Series B), Investors in Chemicals (Series B), Investors in Drug Delivery (Series A), Investors in Diagnostics (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Drug Delivery (Series B), Investors in Drug Delivery (Seed), Investors in Diagnostics (Series B), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A)
+55
Photo of Nathan Livingston, Analyst at Catalio Capital
Nathan Livingston
Catalio CapitalAnalyst
n/a
$1.5M
($100K - $5.0M)
Investors in Baltimore (MD)
Investors in Semiconductors (Series A), Investors in Semiconductors (Seed), Investors in Semiconductors (Seed), Investors in Semiconductors (Series A), Investors in Washington, D.C. (Other Lists), Investors in Diagnostics (Seed), Investors in Diagnostics (Series A), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed)
+5
Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Diagnostics investors. The goal is to help Founders find the best investors to target and get introduced to.
Get new data & insights delivered to your inbox
Email address is required.
Firms investing in this space
Catalio Capital
Lockheed Martin Ventures
Northpond Ventures
Add yourself to the list · Suggest Investors · See methodology
Copyright © 2025NFX Capital. We invest.
FAQ Terms Privacy Disclosure
Log in for full access to the Signal investing network

Unlock your intro paths to 30,000+ Pre-Seed, Seed, and Serias A investors. It's free.

Or sign up or log in with email